Health Canada - Note to editors

OTTAWA, July 31, 2014 /CNW/ - Health Canada today released the July 2014 issue of the Canadian Adverse Reaction Newsletter (CARN).

This issue includes an article on the anti-cancer drug cisplatin and the risk of blockage of the aorta, the body's main artery.

It also includes an article on hydroxychloroquine, a drug used for rheumatoid arthritis, lupus, and malaria, and the risk of developing low blood sugar; and a case presentation on a suspected interaction between efavirenz, an HIV drug, and ginkgo biloba, a natural health product.

The edition also contains a quarterly summary of health professional and consumer advisories.

The July 2014 edition of CARN is available on Health Canada's website at: www.health.gc.ca/carn

SOURCE Health Canada



More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.